Allergen Labeling Requirements Across 10+ Global Markets: Complete CPG Guide

Allergen labeling is one of the few areas of CPG compliance where a single missed declaration can pull a product off shelves within days. Every market operates on its own allergen list, declaration format, and enforcement logic, and none of them fully align. This guide briefly breaks down exactly what's required across 10 markets, built as a working reference for QA managers and regulatory affairs teams handling multi-market portfolios.

Key Takeaways

• Allergen declaration rules differ significantly across markets, the allergen list, formatting requirements, cross-contact disclosure rules, and trigger thresholds all vary by jurisdiction
• Canada's front-of-pack nutrition symbols and bilingual allergen requirements took effect in 2026, adding new complexity for North American CPG teams
• The EU recognizes 14 allergens; the US requires 9; South Korea mandates 22 — using a single checklist across markets is a compliance risk, not a shortcut
• AI-assisted review can systematically reduce the compounding risk of managing multi-market allergen compliance manually

Why Allergen Labeling Failures Keep Happening?

The reason allergen errors persist despite decades of regulation is structural. CPG brands are managing declarations across multiple markets simultaneously, each with its own allergen list, formatting rules, and enforcement timeline. A formula change that triggers a label update in the US may simultaneously require review under EU Regulation 1169/2011, Health Canada's SFCR, and FSANZ requirements in Australia. Manual review processes weren't designed for that level of concurrent regulatory complexity. Teams miss updates, artwork revisions don't propagate, and the version sent to print isn't always the version compliance signed off on.

The regulatory environment is tightening, not softening. The FDA now has a published draft CPG (Sec 555.250) specifically addressing major food allergen labeling and cross-contact, issued in May 2023 and pending finalization.

Managing allergen compliance across multiple markets? See how GoVisually's AI Playbooks automate jurisdiction-specific checks, flagging missing declarations and formatting errors in under 30 seconds.

FDA Allergen Labeling Requirements (United States)

Under FALCPA and the FASTER Act (2021), the FDA requires declaration of 9 major food allergens:

(Source: FDA Allergen Labeling FAQ)

How to declare allergens (21 CFR 101.4): Two options, but must be consistent across the entire label,

• Option 1: In the ingredient list — e.g., "flour (wheat)"
• Option 2: Separate "Contains" statement immediately after or adjacent to the ingredient list

Key practice notes:

• "May Contain" / precautionary allergen labeling (PAL) is voluntary and unregulated under FALCPA — but FDA's May 2023 draft CPG signals increasing scrutiny of cross-contact risk management. If you use PAL, ground it in a documented allergen risk assessment.
• Incidental additives exempt from ingredient declaration under 21 CFR 101.100(a)(3) are not exempt from allergen disclosure if they introduce allergen risk.
• Allergen cross-contact is also governed under 21 CFR 117 (cGMP and preventive controls). Juice and seafood processors must additionally address cross-contact in HACCP plans under 21 CFR parts 120 and 123.

EU Allergen Labeling Requirements (European Union)

EU Regulation No. 1169/2011 (FIR) governs allergen labeling across all 27 member states and operates on different logic to the FDA framework. (Source: EUR-Lex — Regulation (EU) No 1169/2011)

The EU recognizes 14 major allergens, including 5 not on the FDA list:

Critical formatting rule (Article 21): Allergens must be visually emphasised within the ingredient list — bold, italic, underlined, or contrasting color. A separate "Contains" statement is permitted but does not replace the emphasis requirement in the ingredient list.

Additional EU requirements to note:

• QUID (Article 22): If an ingredient is featured in the product name or imagery and is a major allergen, its percentage must be declared
• Multi-language markets (Germany, Belgium, Luxembourg, Switzerland): All mandatory food information — including allergen declarations — must appear in the official language(s) of each market

Health Canada and CFIA Requirements (Canada)

Canada's framework is governed by the Safe Food for Canadians Regulations (SFCR), administered by the CFIA.

(Source: CFIA — SFCR Labelling Requirements)

Canada's 14 priority allergens vs. FDA's 9 key differences:

Key operational note: Canada-US sesame alignment (both added 2021–2023) simplifies one aspect — but triticale, bilingual requirements, and new front-of-pack symbols make Canada a distinct regulatory exercise, not just a translation of your FDA label.

Allergen Requirements Across APAC, Middle East, and Other Key Markets

Rather than reviewing each market as a wall of text, here's a quick-reference comparison of all 11 remaining markets:

Managing labels across these markets? GoVisually's EU Regulatory Agent and FDA Regulatory Agent automate first-pass allergen checks by jurisdiction, flagging missing declarations, incorrect emphasis formatting, and species-level gaps before your reviewers see the file.

Building a Multi-Market Allergen Compliance Workflow

Knowing the rules isn't enough. What separates teams that pass retailer audits from those that issue recalls is a repeatable process that applies those rules consistently across every SKU revision.

Step 1: Map your markets before you map your labels

• Document which markets each product targets and which allergen framework applies
• Use custom metadata fields in your review platform to tag every proof with: Target Market, Regulatory Status, Formula Version
• This creates a filterable portfolio view — instantly find "all EU labels pending allergen review" across a 500-SKU range

Step 2: Build market-specific compliance checklists

The FDA framework and EU FIR have structurally different allergen requirements. A single checklist cannot serve both. Build separate checklists for at minimum:

Step 3: Run AI-assisted first-pass review before human review

• Manual allergen review on a complex multi-panel label takes hours and is susceptible to reviewer fatigue
• Automated first-pass review against the specific regulatory framework for that label's target market means your human reviewers address confirmed issues — not hunt for them
• GoVisually's AI Playbooks trigger automatically on file upload, running the relevant regulatory agent, spelling and grammar check, and visual validation in sequence, delivering a violation list with severity level, source rule citation, exact label location, and remediation suggestion

Step 4: Use pixel-level version comparison on every revision

• When a formula change triggers an allergen update, the risk isn't just that the update is wrong — it's that it introduces an unintended change elsewhere
• Diff Highlighting detects every pixel-level change between label versions, confirming only the intended revision was made

Step 5: Lock the approved version and export the compliance record

• Every approved label should generate a documented compliance record: what was checked, who reviewed it, when the approval was given
• Audit trail logs every action — proof uploads, checklist completions, playbook executions, approvals — exportable as a PDF or CSV for regulatory submissions

Frequently Asked Questions

Does the FDA require allergen declarations for incidental additives?

Generally no, incidental additives at insignificant levels with no functional effect are exempt from ingredient declaration under 21 CFR 101.100(a)(3). However, if the additive introduces a major food allergen even at trace levels, it must still be declared. The ingredient exemption does not override FALCPA allergen disclosure obligations.

What is the difference between mandatory and voluntary allergen declarations in the EU?

Under Article 21 of EU Regulation 1169/2011, declaration and visual emphasis of all 14 recognized allergens in the ingredient list is mandatory. Precautionary "May Contain" statements are not required by EU law and are not regulated, EU guidance advises against using PAL as a liability substitute rather than a reflection of genuine cross-contact risk.

Does sesame need to be declared on labels in both the US and Canada?

Yes, sesame became a US major allergen on January 1, 2023 under the FASTER Act. Canada's SFCR already included sesame prior to that date. Both frameworks require explicit declaration, either inline in the ingredient list or in a separate "Contains: Sesame" statement.

What does Natasha's Law require that wasn't required before?

Pre-packaged for direct sale (PPDS) foods — sandwiches, meal kits, bakery items packaged at point of sale — were previously exempt from full ingredient and allergen labeling in the UK. Natasha's Law (effective October 2021) removed that exemption. All PPDS foods now require a full ingredient list with allergen emphasis identical to retail pre-packaged products.

Is Brazil's cross-contact disclosure requirement stricter than the FDA's?

Yes. Brazil's ANVISA RDC No. 26/2015 requires a precautionary cross-contact statement on any product manufactured in a facility that handles allergenic substances — regardless of whether the specific product contains them. The FDA does not mandate precautionary allergen labeling. Brazil's obligation is facility-level, not product-specific.

What happens if a product reformulation adds a new allergen mid-shelf life?

In the US, any reformulation introducing a new major food allergen requires an immediate label update before the reformulated product ships. Distributing a product with an undeclared major allergen is a misbranding violation subject to Class I recall. The same principle applies in the EU, UK, and Canada, allergen status change triggers a mandatory label update, not a discretionary one.

In a nutshell....

The 15 markets covered in this guide don't share a common allergen list, declaration format, or enforcement priority. South Korea requires 22 declared allergens; China's framework is still partially voluntary; Brazil mandates facility-level precautionary statements; Canada requires full bilingual compliance. Managing these with a single checklist and review process is how labeling errors reach shelves. The teams that consistently avoid recalls use structured, market-specific workflows — version control on every revision, documented first-pass reviews citing specific rules, and a clear route for reformulations before they reach print.

Validate labels against FDA, EU, Health Canada, and APAC regulations in one platform. See GoVisually's multi-market compliance tools and run your first automated allergen check today.